Device Trial Radar · NCT02124291
Effect of Assisted Hatching on Vitrified Embryo Transfer Clinical Outcome
Last checked: Nov 19, 2026Latest source record: Apr 26, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
18
Actual
Start
Jun 2014
Primary completion
Dec 2015
Study completion Jun 2016
Sponsor
- Lead sponsor
- Shaare Zedek Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 28, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 42 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of study is to assess the possible impact of assisted hatching on the implantation, pregnancy rate and delivery rate after transfer of vitrified-warmed human embryos.
Conditions
- Complications Associated With Artificial Fertilization
- Placenta; Implantation
- Pregnancy
Interventions
Mechanical Assisted HatchingDevice
The technique of assisted hatching using partial zona pellucida dissection to create an artificial opening of the zona pellucida of early cleaved embryos. While the embryo is stabilized by a holding pipette of micromanipulator, the zona pellucida is pierced with a microneedle that is pushed tangentially through the space between the zona pellucida and blastomeres until it pierces through the zona pellucida again.
Primary outcomes
What the sponsor says the trial is designed to measure.
- delivery rateTime frame: 9 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Shaare Zedek Medical Center
Jerusalem, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.